Insmed: Q4 Earnings Snapshot

BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $160.1 million in its fourth quarter.

On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.21. Losses, adjusted for non-recurring costs, were $1.20 per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1 per share.

The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $59.3 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $65.8 million.

For the year, the company reported that its loss widened to $481.5 million, or $3.91 per share. Revenue was reported as $245.4 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on INSM at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up